There are two common hotspot mutations in the structural domain of EGFR kinase: exon 19 deletion and exon 21 L858R mutation; exon 19 deletion variants account for approximately 45–50% of EGFR variants in non-small cell lung cancer [22]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.